NCT06697665 2024-11-20
An Exploratory Clinical Study to Evaluate the Safety, Tolerability, Immune Response and Preliminary Efficacy of LM103 Injection in Combination With PD-1 in Patients With Advanced Solid Tumours
Suzhou BlueHorse Therapeutics Co., Ltd.
Phase EARLY_PHASE1 Recruiting